» Articles » PMID: 1556402

Quality of Life in Inflammatory Bowel Disease

Overview
Specialty Gastroenterology
Date 1992 Jan 1
PMID 1556402
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Quality of life with inflammatory bowel disease has not been well examined. Recently, a questionnaire to determine subjective health status for patients with inflammatory bowel disease has been developed and verified. To examine the quality of life in a group of "well" outpatients with inflammatory bowel disease, we developed a self-administered form of this questionnaire containing 36 questions identifiable to five dimensions: systemic symptoms, bowel symptoms, functional impairment, social impairment, and emotional function. We identified outpatients with inflammatory bowel disease through the local chapter of the Ileitis and Colitis Foundation and distributed 396 questionnaires, by mail, with 182 being returned completed (46% response rate). Forty-eight age- and sex-matched controls filled out and returned an identical questionnaire. Response options for each question were framed on a seven-point scale in which 7 represented best function and 1 represented worst function. Male-to-female ratio and mean age were similar to those of controls for the inflammatory bowel disease group. In each dimension, as well as globally, the quality of life of patients with inflammatory bowel disease was significantly worse than that for their age- and sex-matched controls. In conclusion, this survey demonstrates that inflammatory bowel disease adversely affects quality of life in a highly motivated group of "well" outpatients when compared to an age- and sex-matched population.

Citing Articles

Patient-Reported Outcomes Measurement Information System as a Clinical Tool for Capturing the Patient Perspective in Pediatric Inflammatory Bowel Disease: A Narrative Review.

Azevedo S, Lopes A Children (Basel). 2025; 11(12.

PMID: 39767921 PMC: 11674067. DOI: 10.3390/children11121492.


Clinical Education: Psychosocial Assessment and Treatment Planning for Patients with Inflammatory Bowel Disease.

Petrik M, Kuhn T, Kinsinger S J Clin Psychol Med Settings. 2024; 31(2):237-244.

PMID: 38734760 DOI: 10.1007/s10880-024-10006-8.


The Multifactorial Etiopathogeneses Interplay of Inflammatory Bowel Disease: An Overview.

MKoma A Gastrointest Disord (Basel). 2023; 1(1):75-105.

PMID: 37577036 PMC: 10416806. DOI: 10.3390/gidisord1010007.


Managing Pregnancy and Nursing Affecting African American Women with Inflammatory Bowel Disease: Clinical Outcomes and Parenthood.

MKoma A, Ware J, Nabaweesi R, Chirwa S Med Res Arch. 2023; 11(6).

PMID: 37492395 PMC: 10367541. DOI: 10.18103/mra.v11i6.3784.


Patient reported outcomes for phosphomannomutase 2 congenital disorder of glycosylation (PMM2-CDG): listening to what matters for the patients and health professionals.

Pascoal C, Ferreira I, Teixeira C, Almeida E, Slade A, Brasil S Orphanet J Rare Dis. 2022; 17(1):398.

PMID: 36309700 PMC: 9618201. DOI: 10.1186/s13023-022-02551-y.